|
|
The 27th Annual Miami Breast Cancer Conference is about introducing new techniques and methods for the treatment of breast cancer. There has been an increase in the women attaining breast cancer. The 27th Annual Miami Breast Cancer Conference will bring together surgical, medical, and radiation oncologists to give information about the primary treatment of breast cancer. The attendees will also get a chance to interact with the medical experts and professionals.
In the conference the following points the speakers will:
- Review current treatment options for benign breast disease, including cosmetic surgery considerations
- Evaluate genomic and proteomic tools for elucidating the biology of breast cancer, identifying new therapeutic targets, assessing recurrence risk, predicting benefit from chemotherapy, and individualizing therapeutic decision making
- Summarize the latest advances in imaging techniques for the detection of breast cancer
- Discuss recent advances in the screening and identification of individuals at high risk for developing breast cancer as well as indications for preventative management strategies such as prophylactic mastectomy and chemoprevention
- Evaluate current and emerging strategies for ameliorating or eliminating therapy-associated adverse events, including premature ovarian failure and lymphedema
- Review the most recent breast cancer treatment data from major international oncology meetings
- Compare sentinel lymph node biopsy to conventional axillary node dissection
- Assess the utility of genomic and/or proteomic technology for elucidating the biology of breast cancer and identifying new therapeutic targets
- Discuss the clinical significance of isolated tumor cells and micrometastases in lymph nodes
- Explain the biology of metastases, patterns of spread, the role of cancer stem cells, and implications for therapeutic design
- Review advances in oncoplastic techniques such as skin-sparing mastectomy, breast-conserving surgery for central lesions, lipofilling, whole-breast reconstruction, DIEP flap, and GAP flap
- Apply innovations in radiation oncology treatment planning and delivery
- Discuss the treatment of HER2+ breast cancer, including patient selection for adjuvant targeted therapy and the development of novel therapeutics for relapsed/refractory metastatic disease
- Evaluate emerging strategies for the treatment of metastatic disease, including novel microtubule-targeted agents and novel combinations with antiangiogenic agents
- Assess the basis for and utility of emerging therapies for triple-negative breast cancer, including poly (ADP-ribose) polymerase inhibitors
- Assess the influence of clinical factors on local recurrence and review management options
- Incorporate optimal chemotherapy selection in the adjuvant setting
- Implement proper surgical planning and use of specialized techniques, including breast-conserving surgery and sentinel node biopsy
- Incorporate radiation therapy for early and advanced breast cancer to improve outcomes and quality of life
- Debate endocrine treatment options for patients with hormone receptor–positive breast cancer, including strategies for the integration of aromatase inhibitors into adjuvant regimens and strategies for overcoming resistance
- Evaluate the role of bone-targeted agents for the management of bone loss and the potential for prevention of metastases
Visitor Profile
The visitors at the 27th Annual Miami Breast Cancer Conference are as follows:
- Medical Experts
- Surgical Doctors
- Medical Students
- Medical Institutions
- Radiation Oncologists
- Professional
- Media
- Publishers
Organizer
Physicians' Education Resource
